These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 30027649)

  • 41. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E
    Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study.
    Stepien K; Nowak K; Zalewski J; Pac A; Undas A
    Vascul Pharmacol; 2019 Sep; 120():106567. PubMed ID: 31158568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of direct oral anticoagulants-associated bleeding in the trauma patient.
    von Heymann C; Rosenthal C; Kaufner L; Sander M
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):220-8. PubMed ID: 26934279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020].
    Auditeau C; Talbot A; Blandinières A; Smadja DM; Gendron N
    Bull Cancer; 2020 May; 107(5):574-585. PubMed ID: 32252973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.
    Robertson L; Kesteven P; McCaslin JE
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010956. PubMed ID: 26123214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies.
    Liu X; Xu ZX; Yu P; Yuan P; Zhu WG
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):569-578. PubMed ID: 32297024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
    Overstad S; Tjonnfjord E; Garabet L; Fronas S; Bergan J; Aballi S; Ghanima W
    Thromb Res; 2020 Oct; 194():116-118. PubMed ID: 32788102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials.
    Rojas-Hernandez CM; Oo TH
    Drugs; 2019 Apr; 79(6):621-631. PubMed ID: 30905033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish population.
    Cerdá M; Cerezo-Manchado JJ; Johansson E; Martínez F; Fernández M; Varela A; Rodríguez S; Bosch F; Santamaría A
    J Comp Eff Res; 2019 Feb; 8(3):165-178. PubMed ID: 30654626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants.
    Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B
    J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Pollack CV
    Circulation; 2016 Jan; 133(2):e18-9. PubMed ID: 27028439
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
    Arachchillage DR; Besser M; Maclean R; Baglin T; van Veen JJ
    Thromb Res; 2016 Jul; 143():137-40. PubMed ID: 27244105
    [No Abstract]   [Full Text] [Related]  

  • 55. Nonvitamin K Antagonist Oral Anticoagulant in Patients With Venous Thromboembolism and Polycythemia Vera or Essential Thrombocythemia: A Cohort Study.
    Weronska A; Papuga-Szela E; Broniatowska E; Undas A
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e743-e748. PubMed ID: 34321399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence.
    Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Spolveri S; Panigada G; Landini G
    Thromb Res; 2018 Dec; 172():165-168. PubMed ID: 30419471
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of Direct-Acting Oral Anticoagulant Use in Patients With Cancer.
    Davis DO; Davis KA
    J Pharm Pract; 2018 Oct; 31(5):441-444. PubMed ID: 28803521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
    Sardar P; Chatterjee S; Lavie CJ; Giri JS; Ghosh J; Mukherjee D; Lip GY
    Int J Cardiol; 2015 Jan; 179():279-87. PubMed ID: 25464465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants.
    Olivera P; Gabilondo M; Constans M; Tàssies D; Plensa E; Pons V; Las Heras G; Jiménez C; Campoy D; Bustins A; Oliver A; Marzo C; Canals T; Varela A; Sorigue M; Sánchez E; Ene G; Perea G; Vicente L; López M; Cerdá M; Johansson E; Aguinaco MR; Santos N; Mateo J; Reverter JC; Moya Á; Santamaría A
    Med Clin (Barc); 2018 Sep; 151(5):210.e1-210.e13. PubMed ID: 29602444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of pulmonary embolism.
    Décousus H; Mismetti P; Couturaud F; Ageno W; Bauersachs R
    Presse Med; 2015 Dec; 44(12 Pt 2):e393-9. PubMed ID: 26547678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.